Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive disorder characterized by onset of megaloblastic anemia associated with decreased serum vitamin B12 (cobalamin, Cbl) in infancy or early childhood. Low molecular weight (LMW) proteinuria is frequently present, but usually occurs later and is usually mild or subclinical. Patients often present with vague symptoms, including failure to thrive, loss of appetite, fatigue, lethargy, and/or recurrent infections. Treatment with vitamin B12 results in sustained clinical improvement of the anemia. The proteinuria is nonprogressive, and affected individuals do not have deterioration of kidney function; correct diagnosis is important to prevent unnecessary treatment. The disorder results from a combination of vitamin B12 deficiency due to selective malabsorption of the vitamin, and impaired reabsorption of LMW proteins in the proximal renal tubule. These defects are caused by disruption of the AMN/CUBN complex that forms the 'cubam' receptor responsible for intestinal uptake of B12/GIF (CBLIF).
Features include always present findings: Decreased circulating vitamin B12 concentration; and very common findings: Protein in the urine (proteinuria). 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 3 | Recurrent urinary tract infections, Reduced kidney function (renal insufficiency), Protein in the urine (proteinuria) |
AMN encodes amnion associated transmembrane protein (453 aa). Membrane-bound component of the endocytic receptor formed by AMN and CUBN. Required for normal CUBN glycosylation and trafficking to the cell surface. Highest expression in Small Intestine Terminal Ileum (95.7 TPM) and Colon Transverse (60.9 TPM).
Imerslund-Grasbeck syndrome type 2 is associated with mutations in the AMN gene on chromosome 14.
The AMN protein participates in Defective AMN causes MGA1, Defective AMN does not transport GIF:Cbl, and Defective CUBN does not transport GIF:Cbl pathways.
AMN is classified as a druggable target with score 0.0.
Genetic testing for AMN is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Imerslund-Grasbeck syndrome type 2 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 very common feature, 2 common features.
No clinical trials have been registered for Imerslund-Grasbeck syndrome type 2.
7 publications have been identified in PubMed for Imerslund-Grasbeck syndrome type 2. Research spans Case Report / Case Series (57%), Other (14%), and Diagnostic / Biomarker (14%).
Lerdkrai C (2026). [PMID: 41938542](https://pubmed.ncbi.nlm.nih.gov/41938542/). *Vet World*. [Diagnostic / Biomarker]
Sakakibara N (2025). [PMID: 40163114](https://pubmed.ncbi.nlm.nih.gov/40163114/). *Pediatric nephrology (Berlin, Germany)*. [Case Report / Case Series]
Pietrobon A (2025). [PMID: 39911140](https://pubmed.ncbi.nlm.nih.gov/39911140/). *Canadian journal of kidney health and disease*. [Case Report / Case Series]
Xing L (2025). [PMID: 40963966](https://pubmed.ncbi.nlm.nih.gov/40963966/). *Frontiers in pediatrics*. [Case Report / Case Series]
Di Sario F (2024). [PMID: 39294696](https://pubmed.ncbi.nlm.nih.gov/39294696/). *Italian journal of pediatrics*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 17, 2026, 9:52 PM UTC
Online Mendelian Inheritance in Man
Common questions about Imerslund-Grasbeck syndrome type 2
Blood and immune system |
3 |
Recurrent urinary tract infections, Low red blood cell count (anemia), Megaloblastic anemia |
Digestive system | 1 | Diarrhea |
Bones and joints | 1 | Lumbar kyphosis |
Growth and development | 1 | Growth delay |
Yang J (2024). [PMID: 38992620](https://pubmed.ncbi.nlm.nih.gov/38992620/). *BMC nephrology*. [Other]
Mucha P (2024). [PMID: 39125597](https://pubmed.ncbi.nlm.nih.gov/39125597/). *International journal of molecular sciences*. [Review / Meta-Analysis]